Clinical Trials on ALK Advanced NSCLC
Total 435558 results
-
AstraZenecaCompletedT790M Positive NSCLC PatientsChina
-
PfizerTerminatedAdvanced Solid Tumors | Advanced CancerUnited States
-
BeiGeneActive, not recruitingNonsmall Cell Lung Cancer, Stage IV | Locally Advanced, Unresectable, or Metastatic Nonsmall Cell Lung Cancer (NSCLC)United States, China, Korea, Republic of, France, Spain, Australia, Austria
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingNSCLC Stage IV | ALK Fusion Protein ExpressionUnited States
-
LMU KlinikumDepartment of Internal Medicine V, Thoracic Oncology Centre Munich, LMU Munich... and other collaboratorsRecruitingOncology | NSCLC, Stage III | Chemoradiotherapy | Biomarker | DurvalumabGermany
-
The Affiliated Hospital of Qingdao UniversityUnknownNSCLC Stage IV | PD-1 | ARID1AChina
-
Myriad Genetic Laboratories, Inc.TerminatedNSCLC | Lung Cancer | NSCLC AdenocarcinomaUnited States
-
Jun Zhang, MD, PhDNilogen OncosystemsRecruitingNSCLC | Lung Cancer | NSCLC Stage IVUnited States
-
Harbin Medical UniversityJiangsu HengRui Medicine Co., Ltd.Unknown
-
Vividion Therapeutics, Inc.RecruitingAdvanced Solid Tumors | Advanced Hematologic TumorsUnited States, Australia
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesChina
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesUnited States
-
STORM Therapeutics LTDRecruitingCancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors, Neoplasms, Advanced SolidHungary
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer Relapsed | Advanced Cancer Refractory
-
Astellas Pharma Global Development, Inc.WithdrawnSubjects With NSCLC With an EGFR Activating Mutation
-
The First Affiliated Hospital of Guangzhou Medical...UnknownPulmonary Metastases | NSCLCChina
-
Vestre Viken Hospital TrustOdense University Hospital; Karolinska University Hospital; Oslo University Hospital and other collaboratorsRecruitingCancer | Lung Cancer | NSCLC Stage IV | Mutation | NSCLC, Stage III | Lung Cancer Stage IV | Cancer, LungNorway
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Fudan UniversityCompletedNSCLC Stage IV | EGFR Activating MutationChina
-
Megan Daly, MDEMD SeronoCompletedMetastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Yonsei UniversityUnknownCompletely Resected NSCLC With Common EGFR MutationsKorea, Republic of
-
National Cancer Institute (NCI)RecruitingSCLC | Advanced Solid Tumor | Small Cell Cancer | High Grade Neuroendocrine CancersUnited States
-
Zhejiang UniversityRecruitingAdvanced Colorectal Cancer | Advanced Hepatocellular Carcinoma | Advanced Gastric Cancer | Advanced Pancreatic CancerChina
-
Baodong QinUnknownNSCLC Stage IV | Anlotinib | EGFR T790M-negative | JS001China
-
Vestre Viken Hospital TrustOslo University Hospital; University Hospital of North Norway; Helse Stavanger... and other collaboratorsRecruitingOncology | NSCLC Stage IV | NSCLC, Stage IIINorway
-
Teon Therapeutics, Inc.Merck Sharp & Dohme LLCTerminatedCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
BiOneCure Therapeutics Inc.RecruitingCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedAdvanced Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
Tianjin Medical University Cancer Institute and...Not yet recruitingNSCLC | EGFR Activating Mutation | Anlotinib | TP53 | Aumolertinib
-
Shandong Provincial HospitalUnknown
-
National Taiwan University HospitalRecruiting
-
Maastricht University Medical CenterKU Leuven; University College, London; Erasmus Medical Center; Catholic University... and other collaboratorsRecruitingNSCLC Stage IV | Metastatic DiseaseBelgium, Netherlands, United Kingdom, France, Germany, Italy
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLS With Exon 20 Insertion MutationUnited States, Spain, Canada, Italy, Israel, Japan, United Kingdom, Korea, Republic of, Germany, France, Turkey, Belgium, Netherlands, Philippines, Poland, Singapore
-
iTeos Belgium SARecruitingMetastatic NSCLC | Stage III NSCLCUnited States, Belgium, Spain, Switzerland, Italy, France, Canada, Poland, Czechia
-
Advanced Integrative Medical Science InstituteRecruitingNeoplasms | Advanced Solid Tumor | Advanced Cancer | Oncology | Neoplasm MalignantUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteNestle Health ScienceWithdrawnNSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | NSCLC Stage IIIB | Non-small Cell Lung Cancer Stage IIIB | NSCLC, Stage IIIA | Non-small Cell Lung Cancer Stage ⅢAUnited States
-
PfizerFrench College of General Hospital Pneumologists (CPHG)CompletedNSCLC | Crizotinib | ALK Gene Rearrangement or ROS1 Gene RearrangementFrance
-
Chinese University of Hong KongPamela Youde Nethersole Eastern HospitalCompleted
-
Shanghai Chest HospitalGeneplus-Beijing Co. Ltd.; Guangzhou Burning Rock Medical Examination Institute... and other collaboratorsUnknownNSCLC | Malignant HydrothoraxChina
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
NantCell, Inc.CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced Malignancy
-
Centre Francois BaclesseHoffmann-La Roche; Groupe Français de Pneumo-CancérologieTerminatedNSCLC Patients With EGFR Activating MutationFrance
-
Shanghai Miracogen Inc.RecruitingAdvanced Solid Tumors | Advanced or Metastatic Gastric Cancer | Advanced or Metastatic Gastroesophageal Junction CancerUnited States